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Abstract: Guided bone regeneration (GBR) has been estab-
lished to be an effective method for the repair of defective tis-
sues, which is based on isolating bone defects with a barrier
membrane for faster tissue reconstruction. The aim of the
present study is to develop poly (hydroxybutyrate-co-3-hydro-
xyvalerate) (PHBV)/fibrinogen (FG)/bredigite (BR) membranes
with applicability in GBR. BR nanoparticles were synthesized
through a sol–gel method and characterized using transmis-
sion electron microscopy and X-ray diffractometer. PHBV,
PHBV/FG, and PHBV/FG/BR membranes were fabricated using
electrospinning and characterized by scanning electron
microscopy, Fourier transform infrared spectroscopy, contact
angle, pore size, thermogravimetric analysis and tensile
strength. The electrospun PHBV, PHBV/FG, and PHBV/FG/BR
nanofibers were successfully obtained with the mean diame-
ter ranging 240–410 nm. The results showed that Young’s
modulus and ultimate strength of the PHBV membrane
reduced upon blending with FG and increased by further
incorporation of BR nanoparticles, Moreover hydrophilicity of
the PHBV membrane improved on addition of FG and BR. The
in vitro degradation assay demonstrated that incorporation of
FG and BR into PHBV matrix increased its hydrolytic degrada-
tion. Cell-membrane interactions were studied by culturing
human fetal osteoblast cells on the fabricated membrane.
According to the obtained results, osteoblasts seeded on
PHBV/FG/BR displayed higher cell adhesion and proliferation
compared to PHBV and PHBV/FG membrane. Furthermore,
alkaline phosphatase activity and alizarin red-s staining indi-
cated enhanced osteogenic differentiation and mineralization
of cells on PHBV/FG/BR membranes. The results demon-
strated that developed electrospun PHBV/FG/BR nanofibrous
mats have desired potential as a barrier membrane for
guided bone tissue engineering. © 2019 Wiley Periodicals, Inc. J
Biomed Mater Res Part A: 107A: 1154–1165, 2019.
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INTRODUCTION
Guided bone regeneration (GBR) demonstrated to be an
effective method to regenerate bone tissue in the defect
sites, which involve the creation and maintenance of a
secluded space by using a barrier membrane to prevent the
migration of epithelial and other soft tissues into the osseous
defective area, thereby allowing sufficient time for the regen-
eration of bone.1–3 To achieve the effective GBR approach,
the barrier membrane should have specific properties such
as biocompatibility, bioactivity (osteoconductivity), cell-
occlusiveness, mechanical stability (space maintaining abil-
ity), resorbability, and clinical operability.4,5 A number of
natural and synthetic polymers have been developed as the
resorbable membranes for GBR applications such as poly
(lactic-co-glycolic acid), polycaprolactone, poly hydroxyalk-
anoates, gelatin, chitosan, and collagen.2,4–7 Among all kinds
of membrane polymers, poly (3-hydroxybutyrate-co-
3-hydroxyvalerate) (PHBV) is a promising biomaterial which
has been extensively investigated for bone tissue engineer-
ing. PHBV is a biodegradable polyester, produced by bacteria
with attractive characteristics in the field of biomedical
applications, such as natural origin, biocompatibility, and
biodegradability.8,9 Moreover, PHBV degrades in vivo into
hydroxybutyric acid, which is a normal constituent of human
blood.10 However, when considering its application in bone
tissue engineering, PHBV is associated with several major
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disadvantages such as hydrophobic nature and lack of
cell-recognizable sites, low degradation rate compared with
typical bone healing time and poor bioactivity (bone regen-
eration capacity).11 Combination of PHBV with inorganic bio-
active phases and natural components with higher
hydrophilicity, bioactivity and degradation rate may be an
effective approach to overcome its intrinsic shortcoming.
Bredigite (BR, Ca7MgSi4O16) is a magnesium silicate based
bioceramic, which have the ability to form bone-like apatite
in the simulated body fluid and can enhance cellular activ-
ity.12 Wu et al.13 demonstrated the enhanced mechanical
properties and higher apatite mineralization ability and deg-
radation rate of BR bioceramic compared to Ca–P ones as
well as the ability to support the osteoblasts adhesion and
proliferation. The application of BR bioceramic in bone tissue
engineering was reported by Zhou et al.,14 whereby the ionic
products from the dissolution of the BR significantly
enhanced the periodontal ligament cells proliferation, alka-
line phosphatase (ALP) activity, mineralization, and osteo-
genesis/cementogenesis-related gene/protein expression in
bone tissue regeneration.
Fibrinogen, a fibrous blood plasma glycoprotein, has long
been of interest in creating scaffolds for wound healing and
hemostasis. Its inherent ability to induce cell adhesion,
proliferation and migration, as well as its degradability, non-
immunogenicity and ability to undergo biomimetic minerali-
zation, make it an attractive biopolymer for the development
of bone tissue engineering scaffolds.15,16 Considering the
advantages of BR and fibrinogen toward cellular activity, we
applied these two components to overcome the shortcoming
of PHBV polymer in GBR applications.
Nanofibrous materials have been widely used as desired
membranes for tissue engineering applications. In addition
to inherent flexibility, nanofibrous membranes can provide
high area-to-volume ratios structures which mimic the extra-
cellular matrix (ECM) of native tissue, hence capable of
inducing cellular adhesion and growth.17–19 The most stud-
ied techniques for fabricating nanofibrous membrane are
phase separation, self-assembly, and electrospinning.20
Among them, electrospinning attracted rapidly growing
interests due to its ease of use and affordable instrumental
set-up without any complex equipment.21 Moreover,
mechanical, chemical and biological characteristics of elec-
trospun structures can be altered in order to obtain favor-
able biomimetic materials with enhanced cellular
responses.16 Furthermore, since the pore size of the electro-
spun membranes is smaller than the average cell size, the
membranes can prevent cell penetration but allow nutrient
materials and oxygen diffusion into, and metabolic waste out
of the area of tissue regeneration.22
In the present study, a novel biomimetic GBR membrane
was fabricated using PHBV, BR nanoparticles and fibrinogen
via electrospinning. We expected that the combination of BR
nanoparticles and fibrinogen with PHBV in the form of nano-
fibrous structures would produce a biomimetic membrane
with enhanced mechanical strength, bioactivity, and cellular
response. The morphological, chemical, and mechanical
properties of the resultant membranes were investigated,
and the cell-membranes interactions were evaluated by cul-
turing human fetal osteoblast (hFob) cells on the developed
membranes to assess the suitability of the developed mem-
branes for guided bone regeneration.
MATERIALS AND METHODS
Preparation of BR nanoparticles
BR nanoparticles were synthesized using sol–gel method as
described in our previous study.23 Briefly, tetraethyl orthosi-
licate (TEOS, Merck) was mixed with nitric acid (2 M, Merck)
and water (mole ratio: TEOS/nitric acid/water = 1:0.08:4)
and hydrolyzed for 30 min under stirring. Ca(NO3)2.4H2O
and Mg(NO3)2.6H2O were then added to the mixture (mole
ratio: TEOS/Ca(NO3)2.4H2O/Mg (NO3)2.6H2O = 4:7:1), and
the solution was stirred at room temperature for 5 h. The
prepared sol was kept at 60C for 24 h and dried at 120C
for 48 h to get a dried gel, which was then calcined at
1150C for 2 h with a heating rate of 5C/min. Finally, it
was ball-milled in a zirconia mechanical ball mill and charac-
terized using transmission electron microscopy (TEM; JEOL
JEM-2010F) and X-ray diffractometer (XRD; Philips X’Pert-
MPD, Cu Ka radiation at 30 mA and 40 kV, at a scan rate of
3/min).
Fabrication of nanofibrous membranes
PHBV, PHBV/fibrinogen, and PHBV/fibrinogen/BR nanofi-
brous membranes were fabricated using electrospinning
technique. Briefly, PHBV (TianAn Enmat chemical company,
China) was dissolved in 1,1,1,3,3,3 hexafluoro-2-propanol
(HFIP, Sigma) to obtain 8 wt % pure PHBV solution.
PHBV/fibrinogen solution was prepared by dissolving PHBV
polymer and fibrinogen (Sigma; PHBV/fibrinogen: 80/20
[w/w]) in HFIP to make a total concentration of 8 wt %. To
prepare PHBV/fibrinogen/BR solution, BR nanoparticles
(10 wt % of total content) was sonicated for 30 min in HFIP;
further PHBV/fibrinogen (80/20) was added to this mixture
to obtain 8 wt % polymer composite solutions. All prepared
solution including pure PHBV, PHBV/fibrinogen, and
PHBV/fibrinogen/BR solution were stirred overnight at
room temperature, loaded into a 3 mL syringe, and pumped
through a needle of 0.5 mm internal diameter. The high volt-
age (Gamma High Voltage Research, FL) of 14 kV was
applied to the polymeric solution. The constant flow rate of
1 mL/h was fixed using a syringe pump (KD 100 Scientific
Inc., Holliston, MA) at a distance of 15 cm which maintained
between the needle tip and the collector. The electrospun
nanofibrous membranes were dried in a vacuum oven for
24 h to eliminate residual solvent and then kept in a desicca-
tor for further characterization and cell culture study.
PHBV/fibrinogen and PHBV/fibrinogen/BR nanofibrous
membrane were termed as PHBV/FG and PHBV/FG/BR,
respectively.
Characterization of nanofibrous membranes
The morphology of electrospun membranes was observed
by field-emission scanning electron microscopy (FESEM:
HITACHI S-4300, Japan). The diameter of the obtained nano-
fibers was measured from FESEM images using ImageJ
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software (Image Java, National Institutes of Health, Bethesda,
MD). The wet-up/dry-up method of capillary flow porometer
(1200-AEHXL capillary flow porometer, Porous Materials
Inc., Ithaca, NY) was used to determine the membranes pore
diameter. Samples were punched into 20 mm-diameter
round mats and their thickness was measured using a
micrometer. The pore size was calculated by the software
from Porous Media Inc (Ithaca, NY) as a function of the sur-
face tension of the wetting liquid, the contact angle of the
wetting liquid, and differential pressure. Surface wettability
of the nanofibrous membranes was investigated by a video
contact angle system (VCA optima, AST Products, Billerica,
MA). The water contact angle on three different positions
was measured and recorded for each sample. The mechani-
cal strength of the fabricated membranes was tested and
determined using a tabletop tensile tester (Instron 5943)
with a load cell of 50 N. The nanofibrous membranes were
cut into rectangular strips (10 × 20 mm) mounted vertically
on the gripping unit and tested at a crosshead speed of
10 mm/min. Tensile stress, elongation at break and elastic
modulus were calculated from the generated tensile stress–
strain curves. At least five samples were tested for each type
of the membranes. Fourier transform infrared (FTIR) spec-
troscopic analysis of nanofibrous membranes was performed
on Avatar 380 spectrophotometer (Thermo Nicolet, Waltham,
MA) over a range of 400–4000 cm−1 at 4 cm−1. Thermal
properties of the electrospun membranes were examined by
thermogravimetric (TGA) experiments using STA 503 (Bahr,
Germany). All the samples were pre-weighed and subjected to
a programmed heating in the temperature range of 30C–
600C at a rate of 10C/min.
In vitro biodegradation of the nanofibrous membranes
Electrospun membranes were cut into 10 × 10 mm2 pieces,
weighted, and placed into the plastic tubes containing 10 mL
of phosphate buffer solution (PBS, Sigma-Aldrich) at pH 7.3.
The tubes were kept at 37C for 28 days. PBS was replaced
with a new solution every 3 days. At each time interval, the
samples were washed with water, dried in a vacuum oven at
room temperature, and weighed again. The percentage of
weight loss was calculated based on the equation:
([W0 – WT]/W0) × 100, where W0 is the weight of the sam-
ple before test and WT is the weight of the sample after deg-
radation period of time. An average of six measurements
was taken for each sample. The changes in the surface mor-
phology of the nanofibrous membranes during degradation
assay were visualized by SEM.
Culture of hFob cells
The hFob cells, obtained from the American Type Culture
Collection (ATCC, VA 20108, USA), were cultured in Dulbec-
co’s modified eagles medium/nutrient mixture F-12
(DMEM/F12, Sigma Aldrich, Singapore), supplemented with
10% fetal bovine serum (FBS, GIBCO, Invitrogen Corp) and
1% antibiotic solution (Sigma–Aldrich, A5955) in a 75 cm2
cell culture flask, which was then incubated in CO2 incubator
at 37C and 5% CO2. After confluency, cells were detached
by trypsin/EDTA (GIBCO, Invitrogen Corp) and seeded on
the nanofibrous membranes at the seeding density of 104
cells/well. To study cell-membranes interactions, the nanofi-
brous membranes which were previously collected on the
15 mm coverslips, were placed in a 24-well plate, sterilized
using UV light for 2 h, washed three times with PBS for
15–20 min, and immersed in complete medium (DMEM/
F12-10% FBS-1% antibiotics) overnight prior to culturing of
osteoblasts.
Cell proliferation. The hFob proliferation on the electrospun
membranes was evaluated using the colorimetric MTS assay
(CellTiter 96 Aqueous One solution; Promega, Madison). The
yellow tetrazolium compound in MTS reacts with the viable
cells to generate a purple soluble formazan product, which
can be detected using absorbance measurements at 490 nm.
The amount of generated formazan dye is directly propor-
tional to the number of cells. After 5, 10, and 15 days of cell
culture, the media was discarded from the wells and the cells
were rinsed with PBS and incubated with MTS reagent (20%)
in serum-free medium in 5% CO2 incubator at 37C for 3 h.
After the incubation period, the obtained dye was aliquoted
into 96-well plates and read using a spectrophotometric plate
reader (FLUO star OPTIMA, BMG lab Technologies, Germany).
The experiments were done in three replicates and the cells
grown on tissue culture plastic (TCP) served as the control.
ALP activity. The expression of ALP by cells is a marker of
osteoblastic maturation and differentiation, which can be
measured by applying alkaline phosphate yellow liquid sub-
strate system for ELISA (Sigma Life Sciences). After 5, 10,
and 15 days of culturing, the medium was aspirated from
the wells and cells were rinsed with PBS and incubated with
ALP solution (400 μL) for 1 h at room temperature. The ALP
activity was stopped by addition of 100 μL of 2 N NaOH
solution following which the yellow color product was ali-
quoted in 96-well plates and read in spectrophotometric
plate reader at 405 nm.
Alizarin red-S. Alizarin red-S (ARS) staining was used to
evaluate calcium-rich deposits produced by hFob. After
5, 10, and 15 days of cell seeding, the nanofibrous mem-
branes with cells were washed thrice with PBS and fixed in
ice-cold ethanol (70%) for 1 h. The fixed samples were then
rinsed thrice with distilled water and stained with ARS
(Sigma Aldrich, 40 mM) for 1 h in an incubator at 37C.
Microscopic images of the stained cells visualizing the miner-
alization were taken using an optical microscope. For quanti-
tative detection of mineral deposits, the stained cells were
washed two times with deionized water and treated with
cetylpyridinium chloride (10%, Sigma Aldrich) for 1 h. The
desorbed dye was collected and its absorbance was mea-
sured at 540 nm using a spectrophotometer (Thermo Spec-
tronic). The experiment was conducted in three replicates to
plot the graph for osteoblasts mineralization.
Cell morphology and energy dispersive X-ray spectroscopy
(EDS). FESEM was used to evaluate cell morphology and
mineral secretion of hFob seeded on different nanofibrous
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membranes. After 5 and 15 days of the cell culture, the
media was removed from the wells and the samples were
rinsed with PBS and fixed with 3% glutaraldehyde in PBS
for 3 h. The membrane with cells were then rinsed with dis-
tilled water for 15 min and then dehydrated with a series of
ethanol solutions of increasing concentrations (30%, 50%,
75%, 90%, and 100% [v/v]). Finally, the cells were treated
with hexamethyldisilazane (Sigma Aldrich) and left to dry
overnight at room temperature. The dried samples were
observed under FESEM-EDS.
Statistical analysis
All experiments were performed three times and the results
were shown as the mean value and standard deviations.
One-way analysis of variance (ANOVA) with pairwise post-
hoc Tukey was used to evaluate the differences between the
different groups or time points. A p value of 0.05 was con-
sidered statistically significant.
RESULTS
Characterization of the nanoparticles and nanofibrous
membranes
X-ray diffraction (XRD) pattern and TEM image of the BR
nanoparticles are shown in Figure 1. The obtained experi-
mental XRD pattern was in good agreement with the stan-
dard card of BR (JCPDS: 036–0399). TEM micrograph
indicated the production of irregular shaped nanoparticles
with the average size of 25 nm. The typical FESEM images of
as-electrospun PHBV, PHBV/FG, and PHBV/FG/BR nanofi-
brous membranes along with the histograms of the nanofi-
ber diameters are given in Figure 2. The average fiber
diameters of the electrospun membranes are summarized in
Table I. The bead-free and relatively uniform PHBV nanofi-
bers were obtained with the fiber diameter of 410  61 nm,
without the formation of tiny short nanofibers. Blending
fibrinogen with PHBV yielded a decrease in average fiber
diameter (240  96 nm) for PHBV/FG nanofibers along with
the formation of short and tiny nanofiber elongated from the
large fibers. On BR nanoparticles incorporation into the
FIGURE 1. Structural properties of bredigite nanoparticles, (a) XRD pattern of bredigite nanoparticles, (b) TEM image of bredigite nanoparticles.
TEM, transmission electron microscopy; XRD, X-ray diffraction.
FIGURE 2. FESEM images, corresponding fiber size distribution and
images of water droplet on (A) PHBV, (B) PHBV/FG, and (C) PHBV/
FG/BR membranes. BR, bredigite; FESEM, field-emission scanning
electron microscopy; FG, fibrinogen; PHBV, poly (hydroxybutyrate-
co-3-hydroxyvalerate).
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nanofibers, the average fiber diameter increased slightly to
315  50 nm for PHBV/FG/BR nanofibers compared to
PHBV/FG nanofibers.
The surface hydrophilicity of a membrane is a key
parameter in inducing cell adhesion and growth, which was
studied by measuring the water contact angle throughout
this work. The results of water contact angle measurements
are summarized in Figure 2 and Table I. PHBV is a naturally
hydrophobic polymer showing a water contact angle value
of 129  6. The incorporation of fibrinogen into the PHBV
matrix significantly reduced the water contact angle of
PHBV/FG membranes to 83  3 (p ≤ 0.05), indicating the
improvement in the membranes hydrophilicity. The
PHBV/FG/BR membranes exhibited lower contact angle (76
 3) compared to PHBV/FG membrane as a result of the
presence of BR nanoparticles, proving the higher hydrophi-
licity of PHBV/FG/BR compared to pure PHBV and PHBV/FG
membranes. The pore size measurement results presented in
Table I indicates that PHBV/FG/BR and PHBV/FG mem-
branes had lower pore diameter (1.38 and 1.05 μm, respec-
tively) when compared to PHBV membranes (2.4 μm).
Similarly, PHBV/FG showed the lowest pore size compared
to other samples; this might be attributed to the smaller
fiber diameter of PHBV/FG.
FTIR spectra of PHBV, PHBV/FG, and PHBV/FG/BR nano-
fibrous membranes are presented in Figure 3A. The spectra
of PHBV membrane displays a peak at 1721 cm−1 responsi-
ble for C O stretching band, the peaks ranging
1230–1430 cm−1 and 835–955 cm−1 corresponds to various
aliphatic C H vibrational bands, and the peaks for C O
vibrational bands at 1170, 1125, and 1020 cm−1.17,24 In the
spectra of blended PHBV/FG and PHBV/FG/BR membranes,
two peaks at 1640 and 1530 cm−1 corresponded to the
amide I and amide II bands of fibrinogen, respectively, and a
broad peak at about 3350 cm−1, which are characteristic
peaks of peptides/protein structures16,25 are observed, in
addition to typical bands of PHBV. In the spectra of
PHBV/FG/BR nanofibers, the peaks at 850 and 961 cm−1
attributed to stretching vibration of silicate structure and
the peak at 507 cm−1 corresponded to Mg O bands
appeared or their intensity increased, in addition to typical
bands of PHBV and fibrinogen.17,23,26 The obtained results
from FTIR analysis confirmed the successful blending of
fibrinogen and BR with PHBV nanofibers.
Thermal properties of nanofibrous membranes were
evaluated by TGA. Figure 3B shows the TGA diagram of
PHBV, PHBV/FG, and PHBV/FG/BR membranes. All nanofi-
brous membranes showed a single stage thermal decomposi-
tion. PHBV decomposed completely in the region of 230C to
300C as shown in Figure 3B, while blending fibrinogen with
PHBV resulted in prolonged decomposition temperature to
400C. In the presence of BR nanoparticles, the curves were
shifted to the higher temperature indicating an increase in
thermal stability of PHBV/FG/BR membranes compared to
PHBV and PHBV/FG nanofibers. The residual weight of
PHBV/FG/BR membranes at the final test temperature was
about 9%, showing the true content of BR nanoparticles in
the membrane, proving that the amount of BR nanoparticles
added to the PHBV/FG solution before electrospinning was
approximately equal to its amount in the PHBV/FG/BR nano-
fibrous membranes after electrospinning.
Mechanical strength of the prepared nanofibrous mem-
branes was found to be influenced by the composition of the
nanofibers. Figure 4A shows the typical stress–strain curves of
the PHBV, PHBV/FG, and PHBV/FG/BR nanofibrous mem-
branes. All samples exhibited a linear segment first, followed
by a nonlinear curve. Key mechanical parameters including
Young’s modulus, tensile strength, and elongation at break,
obtained from their stress–strain curves, are presented in
Figure 4B. The incorporation of fibrinogen into PHBV matrix
reduced Young’s modulus and tensile strength of PHBV/FG
membranes (83.3  15.5 MPa and 3.68  1.1 MPa) compared
TABLE I. Fiber diameter, contact angle and pore size of PHBV
based nanofibrous membranes
Sample
Fiber
diameter
(nm)
Water contact
angle (degree)
Pore
size (μm)
PHBV 410  61 129  6 2.40  0.64
PHBV/FG 240  96 83  3 1.05  0.32
PHBV/FG/BR 315  50 76  3 1.38  0.33
Abbreviations: BR, bredigite; FG, fibrinogen; PHBV, poly (hydroxybu-
tyrate-co-3-hydroxyvalerate).
FIGURE 3. Structural properties of membranes (A) FTIR spectra of PHBV, PHBV/FG and PHBV/FG/BR nanofibrous membranes, (B) TGA diagram of
PHBV, PHBV/FG and PHBV/FG/BR nanofibrous membranes. BR, bredigite; FG, fibrinogen; FTIR, Fourier transform infrared; PHBV, poly (hydroxybu-
tyrate-co-3-hydroxyvalerate); TGA, thermogravimetric analysis.
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to PHBV (106.7  18.2 MPa and 4.4  0.5 MPa). However, the
inclusion of the BR nanoparticles within the nanofibers caused
a significant increase in Young’s modulus and tensile strength
of PHBV/FG/BR (121  14.4 MPa and 5.22  0.7 MPa) com-
pared to PHBV/FG and PHBV membranes (p ≤ 0.05).
In vitro biodegradation of the nanofibrous membranes
In vitro degradation of PHBV, PHBV/FG, and PHBV/FG/BR
nanofibrous membranes were studied by monitoring the
morphological changes and measuring the weight losses of
the membranes during incubation in PBS at 37C. Figure 5A–G
shows the FESEM images of the nanofibrous membranes on
day 14 and 28 after incubation in PBS and the weight loss of
the membranes versus incubation time are plotted in
Figure 5H. As shown in Figure 5, pure PHBV nanofibrous
membranes showed no morphological changes after 14 and
28 days immersion in PBS and the results of weight loss
measurement demonstrated only 3.2% weight loss for pure
PHBV after 28 days of degradation test. PHBV/FG and
PHBV/FG/BR demonstrated more morphological changes
after 14 and 28 days such as fiber adhesion in some parts
and the reduction in fiber diameters. Moreover, it is obvious
in the high-resolution image of PHBV/FG/BR membrane
(Fig. 5G) that the structure of the nanofiber changed to the
porous fiber due to the production of small holes within the
nanofibers as a result of fibrinogen degradation in PBS.
Rapid weight loss of PHBV/FG and PHBV/FG/BR nanofibers
occurred within first 4 days of degradation test (18% and
23%, respectively). The weight loss was then continued dur-
ing degradation up to 28 days with a slower rate of 28%
and 33%, respectively. Hence, the incorporation of fibrino-
gen and BR into PHBV polymer increased its ability to
absorb water during immersion in PBS and, consequently,
increased its hydrolytic degradation.
Cell culture
The proliferation of hFob cells on PHBV, PHBV/FG, and
PHBV/FG/BR membranes after 5, 10, and 15 days of culturing
was investigated using MTS assay and the results are given in
Figure 6a. The cell proliferation rate of all substrates increased
during culture time, and at each time point, PHBV membranes
showed the lowest proliferation rate. The proliferation of hFob
incubated on PHBV/FG membranes was found to be 37% and
40.7% higher than that on PHBV membranes after 10 and
15 days, respectively, due to the presence of fibrinogen. Simi-
larly, the MTS results revealed that PHBV/FG/BR membranes
exhibited the highest proliferation of hFob among other sub-
strates on day 10 and 15. The proliferation of hFob on
PHBV/FG/BR membranes on day 15 was found to be 61.1%
and 14.5% higher than PHBV and PHBV/FG membranes,
respectively.
ALP activity showed increased levels in all samples from
day 5 to day 15, which was in agreement with increased pro-
liferation and maturation of hFob cells (Fig. 6B). The ALP
secretion of the cells grown on PHBV/FG membranes was
shown to be 26% and 29% higher than that on PHBV mem-
branes on day 10 and 15 after cell seeding, respectively.
Moreover, the PHBV/FG/BR nanofibrous membranes dis-
played significantly higher ALP activity than PHBV/FG mem-
brane on day 15 (p ≤ 0.05), due to the synergetic effect of
fibrinogen and BR on the cellular activity.
ARS staining of the cells cultured on the nanofibrous
membranes was performed to study the mineralization of
hFob cells. The results of quantitative and qualitative analy-
sis of ARS staining are shown in Figure 7. As it is obvious
from the microscopic images, the cells on PHBV/FG/BR
nanofibrous membranes induced denser bright red spots
(ARS-calcium chelating products), indicating more mineral
deposition than other membranes and TCP. It is clear from
the plot (Fig. 7B) that after 15 days of cell culture, the eluted
solution collected from PHBV/FG/BR membranes found to
be 20% and 56% higher than those collected from PHBV/FG
and PHBV membranes, respectively.
Cellular morphology and the mineral secretion of the
cells seeded on various membranes were visualized by
FESEM. Figure 8 shows the morphology and density of hFob
FIGURE 4. Mechanical properties of the membranes, (A) Stress–strain curves of PHBV, PHBV/FG and PHBV/FG/BR nanofibrous membranes and
(B) effect of membranes compositions on the ultimate strength, Young’s modulus and elongation at break of the membranes (* indicates a signifi-
cant difference relative to PHBV membranes (p ≤ 0.05), £ indicates a significant difference relative to PHBV/FG membranes (p ≤ 0.05). BR, bredigite;
FG, fibrinogen; PHBV, poly (hydroxybutyrate-co-3-hydroxyvalerate).
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cells on PHBV, PHBV/FG, and PHBV/FG/BR membranes for
5 and 15 days. After 5 days of cell seeding, the cells on
PHBV/FG and PHBV/FG/BR spread more fully with the
physical attachment to the neighboring cells through multi-
ple extensions compared to PHBV membranes. Moreover,
the incubated cells on PHBV/FG/BR membranes exhibited
the formation of many more mineralized deposits on the
surface of osteoblast cells compared to those on PHBV/FG
and PHBV membranes. Higher mineral production ability of
the hFob on PHBV/FG/BR membranes was confirmed by
EDS analysis of the cells. Figure 9 shows the EDS patterns
along with the atomic percentage of elements produced by
osteoblast cells grown on the different substrates, obtained
from EDS analysis on day 15. The results of EDS analysis
showed that the amount of calcium and phosphorous
deposits produced by cells on PHBV/FG and PHBV/FG/BR
nanofibrous membranes was higher than those on PHBV
membranes. Further, the results of EDS analysis demon-
strated the occurrence of the higher content of calcium and
phosphorus deposition on the cultured hFob cells on
PHBV/FG/BR nanofibrous membranes compared to PHBV
and PHBV/FG membranes, proving its higher bone tissue
forming ability.
DISCUSSION
Electrospun nanofibrous materials, mimicking the natural
ECM, have been widely investigated for tissue regeneration
applications. In the context of guided bone regeneration,
these nanofibrous materials are utilized as membranes to
have barrier function which prevent diffusion of fibroblast
and epithelial cells into the defect site and enhance bone
FIGURE 5. FESEM images of (A and D) PHBV, (B and E) PHBV/FG and (C, F, and G) PHBV/FG/BR nanofibrous membranes after (A–C) 2 and (D–G)
4 weeks of degradation in PBS, and (H) weight loss of PHBV, PHBV/FG, and PHBV/FG/BR membranes as function of soaking time (n = 6 samples).
BR, bredigite; FESEM, field-emission scanning electron microscopy; FG, fibrinogen; PBS, phosphate-buffered saline; PHBV, poly (hydroxybutyrate-
co-3-hydroxyvalerate).
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reconstruction by increasing osteoblast adhesion and prolif-
eration. Among the variety of polymers investigated as nano-
fibrous materials for bone tissue engineering, PHBV attracted
more attention due to its natural origin, suitable mechanical
properties, biocompatibility and biodegradability. The combi-
nation of PHBV with bioactive biological materials is reported
to be more desirable in generating nanofibrous materials for
bone tissue engineering, since pure PHBV polymer naturally
has some shortcoming such hydrophobic surface, lack of bio-
activity and poor cellular responses. In the present study, we
reported the development of PHBV nanofibrous membranes
containing fibrinogen and BR with applicability in guided
bone regeneration. The electrospun PHBV, PHBV/FG, and
PHBV/FG/BR membranes were successfully obtained with
interconnected fibrous porous structures composed of ran-
domly oriented fibers. The beadles and relatively uniform
PHBV nanofibers exhibited a fiber diameter of 410  61 nm,
while the blended PHBV/FG nanofibers showed lower mean
fiber diameter with wider diameter distribution compared to
pure PHBV nanofibers. A similar observation was reported in
the literature, whereby the fiber diameter of blended fibrino-
gen nanofiber was found to be decreased by increasing the
concentration of fibrinogen in the blended scaffolds.16,27 The
diameter of the electrospun nanofibers is influenced by
the properties of polymer solutions such as conductivity, sur-
face tension, elasticity and viscosity. Fibrinogen is a macromo-
lecular amphiprotic electrolyte; hence, its incorporation into
the polymer solution increases the charge density and con-
ductivity of the solution. The higher conductivity and charge
density imposes higher elongation forces on the spinning
solution under the electrical field, which results in the
smaller fiber diameters.27 The inclusion of the BR in the
PHBV/FG nanofibers increased the mean fiber diameter of
PHBV/FG/BR nanofibers. However, compared to pure PHBV
nanofibers, PHBV/FG/BR showed the smaller fiber diameter,
which can be in favor of cell adhesion, proliferation and
mineralization.28
The wettability of a membrane regulates the biological
functions, such as cell adhesion, spreading and proliferation
by affecting the surface energy of the membrane, conse-
quently, influencing the absorption of serum proteins on the
membrane surface.29 PHBV nanofibrous membranes showed
the water contact angle of 129  6 due to its hydrophobic
nature. The incorporation of fibrinogen enhanced the hydro-
philicity of PHBV/FG membranes which can be ascribed to
the available carboxyl and amine groups in the structure of
fibrinogen. The PHBV/FG/BR membranes exhibited a more
hydrophilic surface compared to PHBV and PHBV/FG mem-
brane as a result of the presence of BR nanoparticles. Such
hydrophilic characteristic of the PHBV/FG/BR composite
membranes might lead to a better cell adhesion and prolifer-
ation. Pore size is another important property of a GBR
membrane, which has a close relation to the tissue occlusiv-
ity and major effects on the soft tissue cells invasion. In addi-
tion, membrane pores can facilitate the diffusion of oxygen,
fluids, nutrients, and bioactive molecules which is essential
for cell and tissue growth.30–32 In this study, the smaller
fiber diameter of PHBV/FG membrane compared to PHBV
membrane lead to the lower membrane pore diameter. Simi-
larly, the PHBV/FG/BR membranes with higher fiber diame-
ter compared to PHBV/FG showed the higher membrane
pore diameter. When the diameter of the nanofibers
reduced, more layers of fibers can overlap together, which
results in smaller pore size.33 Considering the application to
GBR membranes, the pore size ranges obtained in this study
is adequate to supply nutrients, oxygen, and fluids for cell
growth on porous membranes.34
Mechanical properties of a membrane are essential for
understanding its performance in bone regeneration applica-
tions. The results of mechanical strength test demonstrated
FIGURE 6. Cell proliferation and ALP activity on various membranes, (A) proliferation of hFob cells determined by MTS assay on PHBV, PHBV/FG,
PHBV/FG/BR membranes, and TCP on day 5, 10, and 15, (B) ALP activity of hFob after incubation on PHBV, PHBV/FG, PHBV/FG/BR membranes, and
TCP on day 5, 10, and 15, * indicates a significant difference relative to PHBV membranes (p ≤ 0.05), £ indicates a significant difference relative to
PHBV/FG membranes (p ≤ 0.05). ALP, alkaline phosphatase; BR, bredigite; FG, fibrinogen; hFob, human fetal osteoblast; PHBV, poly (hydroxybuty-
rate-co-3-hydroxyvalerate); TCP, tissue culture plastic.
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that Young’s modulus and tensile strength of PHBV nanofi-
brous membranes got decreased upon blending with fibrino-
gen. Although fibrinogen is a highly bioactive biomaterial but
shows limited mechanical integrity compared to synthetic
polymers.16,35–37 Incorporation of BR nanoparticles within
the nanofibers resulted in a significant increase in Young’s
modulus and tensile strength of PHBV/FG/BR compared to
PHBV/FG and PHBV membranes. In our previous study, it
was demonstrated that the addition of BR nanoparticles into
PHBV nanofibers up to 10% resulted in improved tensile
strength and increased resistance to deformation of PHBV
membranes because of the reinforcement effect of BR nano-
particles within the polymer matrix.17 The increases in stiff-
ness and strength of PHBV/FG/BR membranes can be
considered as an advantageous aspect, especially for the
bone tissue regeneration.
Besides the needful suitable mechanical characteristics,
the biodegradation property is another important parameter
determining the applicability of a GBR membrane. in vitro
degradation performed in PBS revealed that PHBV/FG and
PHBV/FG/BR nanofibrous membranes exhibited more mor-
phological changes and higher degradation rate than pure
PHBV membranes after 28 days incubation in PBS. PHBV is
a hydrophobic polymer and inhibits fast diffusion of water
molecules into the polymer matrix, therefore, it hardly
degrades in neutral pH media without the enzymes.17,38,39 A
common characteristic of natural biopolymers such as fibrin-
ogen is their relatively high degradation rate in the physio-
logical medium. On the other hand, BR is a Si-based
bioceramic which hydrolyzes in the biological environment
within the release of Si ions.14,23 Hence, the incorporation of
fibrinogen and BR into PHBV matrix increases its hydrolytic
FIGURE 7. ARS staining of calcium deposition on TCP (A and E), PHBV (B and F), PHBV/FG (C and G), PHBV/FG/BR (D and H) nanofibrous mem-
branes on day 5 (A–D) and 10 (E–H) and Quantitative estimation of calcium deposition by cetylpyridinium bromide assay on nanofibrous mem-
branes and TCP on day 5, 10 and 15 (I), * indicates a significant difference relative to PHBV membranes (p ≤ 0.05), £ indicates a significant
difference relative to PHBV/FG membranes (p ≤ 0.05). ARS, alizarin red-S; BR, bredigite; FG, fibrinogen; PHBV, poly (hydroxybutyrate-co-3-hydroxy-
valerate); TCP, tissue culture plastic.
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FIGURE 8. SEM micrographs showing the morphology and mineralization of hFob cells on nanofibrous membranes: TCP (A and E), PHBV (B and F),
PHBV/FG (C and G), PHBV/FG/BR (D and H) nanofibrous membranes on day 5 (A–D) and 15 (E–H). BR, bredigite; FG, fibrinogen; hFob, human fetal
osteoblast; PHBV, poly (hydroxybutyrate-co-3-hydroxyvalerate); SEM, scanning electron microscopy; TCP, tissue culture plastic.
FIGURE 9. EDS analysis of the mineral deposition on (A) TCP, (B) PHBV, (C) PHBV/FG, and (D) PHBV/FG/BR after 15 days of cell culture. BR, bredi-
gite; EDS, energy dispersive X-ray spectroscopy; FG, fibrinogen; PHBV, poly (hydroxybutyrate-co-3-hydroxyvalerate); TCP, tissue culture plastic.
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degradation, making it more applicable as a resorbable mem-
brane in guided bone regeneration.
The materials which are applied for fabricating an ideal
GBR membrane must also provide an appropriate environ-
ment for cellular activity such as cell attachment, prolifera-
tion and differentiation as well as allow for tissue
regeneration.40 It is well known that surface wettability of
the biomaterials is an important factor affecting osteoblast
adhesion and proliferation. So, the hydrophobic surface of
PHBV membranes (according to the water contact angle
measurement) is the reason for its lowest cell attachment
and proliferation, when compared to other samples. The
higher proliferation rate of hFob on the PHBV/FG mem-
branes compared to PHBV membranes is attributed to the
presence of fibrinogen. Fibrinogen is a fibrous glycoprotein
which is essential for many biological processes and has the
inherent ability to induce cellular activity. Numerous studies
have confirmed the positive impact of applying fibrinogen on
the in vitro cell adhesion, proliferation, and differentiation as
well as in vivo bone healing/remodeling in bone regenera-
tion applications.41–44 The MTS assay results also revealed
that hFob cells proliferated better on PHBV/FG/BR mem-
branes compared to PHBV/FG, due to the BR nanoparticles
inclusion. Studies have demonstrated that Mg and Si contain-
ing bioceramics can enhance cell adhesion, spreading, prolif-
eration, and differentiation into the osteoblasts.45,46
ALP activity is a marker of the early stage of cell differ-
entiation, since its level increases with the osteoblast cells
maturation. The secretion of ALP regulates the structure of
ECM to progress to the mineralization stage.47 By increasing
the cell proliferation, ALP secretion got increased on all
nanofibrous membranes, however, the ALP activity of the
cells increased more on the PHBV/FG/BR membranes than
on the PHBV and PHBV/FG membranes. The higher level of
ALP activity observed on the PHBV/FG/BR membranes indi-
cates the higher osteoblast activity of hFob, highlighting a
significant synergetic effect between fibrinogen and BR on
hFob differentiation and mineralization.
In the context of guided bone tissue regeneration, nanofi-
brous membranes should not only promote cell attachment,
proliferation, and differentiation but also induce mineral for-
mation in the physiological media, which would, in turn,
accelerate bone formation. The cultured cells on PHBV/FG/
BR and PHBV/FG membranes induced more mineral deposi-
tion compared to PHBV membrane as shown by ARS results,
moreover, mineralization level of hFob cells on PHBV/FG/BR
was found to be higher than on PHBV/FG membranes, which
can be due to the contributory effect of fibrinogen and BR,
confirming the osteogenic potential of cells seeded on
PHBV/FG/BR membranes over the other membranes.
Morphological evidence revealed an increase in cell den-
sity with incubation time for all nanofibrous membranes
with the formation of multilayered mineral particles on the
surface of the cells, indicating the confluent cell growth
and cell-secreted mineralization. Further, PHBV/FG/BR
nanofibrous membranes induced many more mineralized
materials formation on the surface of the cells, suggesting
that fibrinogen and BR are in favor of calcification of the
hFob cells, which was then confirmed by the obtained
results from EDS analysis. The results of EDS analysis again
confirmed the higher mineralization and bone formation
ability of PHBV/FG/BR nanofibrous membrane compared to
PHBV and PHBV/FG membranes. Overall, the results showed
that PHBV/FG/BR nanofibrous membranes developed in this
study have great potential of using as membranes for guided
bone tissue engineering applications.
CONCLUSION
Electrospun PHBV/FG/BR nanofibrous membranes were fabri-
cated and their biological properties were evaluated toward
guided bone tissue engineering applications. The obtained
results demonstrated that the mean fiber diameter and mem-
brane pore size decreased with the addition of fibrinogen and
further increased by incorporation of BR nanoparticles. The
mechanical and thermal properties of resultant membranes
were found to be affected by nanofibers compositions. The
hydrophilicity and degradation rate of PHBV membranes
increased upon the incorporation of fibrinogen and BR, which
were in favor of cell response for proliferation and mineraliza-
tion. in vitro biological evaluation revealed that the osteoblast
cells cultured on PHBV/FG/BR nanofibrous membranes exhib-
ited higher cell proliferation and increased ALP activity and
calcium mineral deposition up to 15 days of cell culture when
compared to PHBV and PHBV/FG membranes. The experimen-
tal data demonstrated that the developed electrospun PHBV/
FG/BR nanofibrous membranes have great potential to be
used for guided bone tissue engineering applications.
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